This study is to collect current information on complications rates of subjects undergoing chemotherapy administration through Ports and peripheral IVs.

Inclusion Criteria:

• Male or female, age ≥ 21 years
• Subject is currently undergoing or has had infusional cancer therapy (solid tumor or hematologic) through a Bard PORT with a distally-valved catheter/open-ended catheter or infusion through a PIV
• Subject had a chemotherapy regimen consisting of a vesicant and/or irritant
• Subject has signed an Informed Consent Form (ICF) or has had an ICF signed by the subject's legally authorized representative

Exclusion Criteria:

• Subject has/had an implanted non Bard PORT

All subjects who are currently undergoing or has had infusional cancer therapy (solid tumor or hematologic) through a Bard PORT with a distally-valved catheter/open-ended catheter or infusion through a Peripheral IV